CytoReason

Bring your data to life

Tel Aviv, Israel · Founded 2016 · $100.0M raised

Headquarters
Tel Aviv
Employees
51–200
Founded
2016
Business Model
B2B
Total Funding
$100.0M
Last Round
$80.0M Series BJul 2024
Rounds
3

About

CytoReason builds computational disease models that digest and organize vast volumes of human molecular data, identifying which genes are active in which cells, pathways, diseases, and drugs. Founded in 2016 to close the gap between exploding data volumes and human analytic capacity, its platform is used by five of the world's top ten pharma companies to prioritize drug targets, find biomarkers, and shorten trial phases.

Summary

CytoReason is an Artificial Intelligence company based in Tel Aviv, Israel, founded in 2016. It has raised $100.0M in total across 3 rounds, most recently a $80.0M Series B round in Jul 2024. Investors include Pfizer Ventures, Nvidia and Thermo Fisher Scientific.

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

Series BSeries BJul 2024
$80.0M

Sign up to see all 3 rounds

Series A through Series B — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

CytoReason on Indexed.vc
<a href="https://indexed.vc/companies/cytoreason"><img src="https://indexed.vc/api/badge/company/cytoreason" alt="CytoReason on Indexed.vc" width="260" height="76" /></a>